Skip to content

IDEXX Laboratories Inc

US · IDXX #543 by market cap Listed 1970
506.67 -8.74 -1.70%
Live - 5344 symbols - heartbeat 139s ago · 2026-10-08 05:47
Pre-market 506.00 -0.13%
After-hours 507.01 +0.07%
Market cap
39.92B
P/B
24.75
EPS
13.08
Reader sentiment Are you bullish or bearish on IDXX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670
    Market Newswire · 2026/8/5
  • Rating change
    BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $660
    Market Newswire · 2026/7/8
  • Rating change
    Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775
    Market Newswire · 2026/2/28
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $620
    Market Newswire · 2026/7/27
  • UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670
    Market Newswire · 2026/9/16
  • Rating change
    Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $729
    Market Newswire · 2026/5/7
  • Rating change
    BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790
    Market Newswire · 2026/4/28
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $730
    Market Newswire · 2026/3/24
  • Rating change
    Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $710
    Market Newswire · 2026/8/11
  • Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
    TipRanks · 2026/9/16
  • Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675
    Market Newswire · 2026/8/14
  • Rating change
    Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $650
    Market Newswire · 2026/4/16
  • BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665
    Market Newswire · 2026/8/14
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $640
    Market Newswire · 2026/4/28
  • Rating change
    BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $660
    Market Newswire · 2026/5/6
  • Rating change
    UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670
    Market Newswire · 2026/8/5
  • Rating change
    Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $675
    Market Newswire · 2026/3/31
  • Rating change
    Citi Initiates IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Announces Target Price $650
    Market Newswire · 2026/4/15
  • William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating
    Market Newswire · 2026/8/14
  • Rating change
    Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805
    Market Newswire · 2026/8/5

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 05:47:24 · For reference only, not investment advice and not tailored to your situation.